almotriptan malate

DRUG4 trials

Sponsors

Janssen-Ortho LLC, Ortho-McNeil Neurologics, Inc.

Conditions

Migraine

Phase 3

A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents

CompletedNCT00210483

Janssen-Ortho LLCMigraine

Start: 2003-07-31End: 2005-07-31Updated: 2011-05-17

A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches

CompletedNCT00257010

Janssen-Ortho LLCMigraine

Start: 2005-12-31End: 2007-12-31Updated: 2014-02-21

Phase 4

The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain

CompletedNCT00212823

Ortho-McNeil Neurologics, Inc.Migraine

Start: 2004-06-30End: 2005-02-28Updated: 2011-05-19

A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache

CompletedNCT00210509

Janssen-Ortho LLCMigraine

Start: 2004-11-30End: 2005-06-30Updated: 2011-05-17